Study of an investigational medicine for fluid buildup in cirrhosis
Part of Blood & lymphatic clinical trials.
This early-stage study tests a new medicine (GLR1075) that may help people with cirrhosis who have fluid in the belly (ascites) and low protein levels (hypoalbuminemia). The trial also checks the medicine in healthy volunteers to understand its safety and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- For the cirrhosis group: be 18 to 65 years old, have cirrhosis with mild to moderate fluid in the belly, and have low blood protein (albumin) levels.
- For the healthy volunteer groups: be 18 to 55 years old with a normal body weight.
- Be willing to use reliable birth control (for those who can become pregnant or father a child) and not donate eggs or sperm during the study.
- Have no major health problems other than cirrhosis (for the cirrhosis group) and no history of cancer in the last 5 years.
- Avoid alcohol, smoking, and excessive caffeine during the study period.
- Be able to attend many study visits and undergo blood draws and other tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests an experimental drug called GK02 for people with advanced cancer who have fluid buildup in the belly (malignant ascites). The drug is given directly into the belly to try to reduce the fluid and control symptoms.
This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.
This Phase 2 trial tests whether high-dose albumin can reduce “refractory ascites,” which is fluid buildup in the belly that doesn’t improve with the highest tolerated water pills (diuretics). If you have liver cirrhosis and need frequent drainage, this study may offer a new treatment option.
This Phase 2 trial tests OsrHSA in people with advanced cirrhosis who have swollen belly fluid (ascites). It aims to see whether the treatment can improve outcomes in this difficult liver condition.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
This trial tests a new protein treatment made from rice to help patients recover from low blood protein levels that sometimes occur after liver surgery. The treatment may help your body heal better after the procedure.
Hear when a new Hypoalbuminemia in Cirrhotic Ascites trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.